• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Baxter hiring thousands to boost COVID-19 supply output

Baxter hiring thousands to boost COVID-19 supply output

April 21, 2020 By Nancy Crotti

BaxterBaxter (NYSE:BAX) told investors today that it is looking to hire 2,000 permanent and temporary workers — including 800 in the U.S. — to produce more supplies needed to treat coronavirus patients.

In a document related to its upcoming  annual meeting, scheduled for May 5, 2020, the company said increased demand for its products spurred the hiring decision. Baxter said last week that it had already begun work to address shortages of kidney dialysis machines and infusion pumps and supplies needed by critically ill patients.

Baxter spokeswoman Lauren Russ told MassDevice in an email today that the company is “hiring for a mix of roles that will help address the increased demand for our products across Baxter’s portfolio.”

The Deerfield, Ill.-based company is seeing increased demand for continuous renal replacement therapy machines, fluids and filter sets for critically ill COVID-19 patients who need round-the-clock dialysis in a few areas. Demand has also spiked for Baxter’s Mini-Bag Plus drug delivery system, Spectrum IQ infusion system and administration sets, IV solutions and some sterile injectables, especially those used in the ICU.

“All Baxter facilities manufacturing these products are running at maximum levels to increase supply as much as possible,” Russ said. “We are really doing everything we can to support hospitals and increase access to the devices and medicines that are in high demand.”

In its statement to shareholders, Baxter also said it is channeling life-saving products where they are needed the most, based on public health reports. While current customers will continue to have access to products, the company said it will dedicate additional inventory to hospitals around the world with the greatest COVID-19 patient care needs and will update those allocations regularly to reflect the dynamic situation.

Baxter also said it has begun shipping more devices and products needed by COVID-19 patients more frequently between the U.S. and Europe. And the company said it is “aggressively” monitoring the availability of and buying incremental raw materials and components.

The company also said it has strengthened worker safety efforts, including infection control measures, limiting work group contact, adding symptom screening and personal protective equipment. It also added a “pandemic incentive” to front-line workers’ pay and offered time off to medically trained personnel to volunteer in their communities.

“Our medically essential products put us on the front lines of this pandemic, and our 50,000 colleagues are rising to the challenge to make a meaningful difference for patients,” said Baxter CEO José Almeida in a separate news release. “Given that demand is at extraordinary levels, it is critical that we prioritize getting our products where they are most needed — hospitals that are being overwhelmed by an influx of patients who are critically ill from COVID-19.”

In March, Baxter posted losses of -$19 million, or -5¢ per share, on sales of $3.04 billion for the three months ended Dec. 31, 2019, dipping below zero on its bottom line after profits of $311 million in this quarter last year, despite sales growth of 7.3%.

The company plans to post Q1 2020 earnings on April 30, when it may offer an update on 2020 earnings guidance.

Baxter employs approximately 50,000 worldwide, with manufacturing in more than 20 countries and sales in 100 countries. Shares in BAX were trading down 3.7% at $19.66 in noontime trading today.

This article has been updated with additional information from Baxter.

Filed Under: Business/Financial News, Dialysis, Drug Pumps, Featured, Hospital Care, Wall Street Beat Tagged With: Baxter, coronavirus, COVID-19

In case you missed it

  • Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
  • 8 drug delivery innovations you need to know
  • Terumo to acquire Health Outcomes Sciences
  • iRhythm’s revenue jumps 33% in Q4
  • Axonics acquires Contura and its Bulkamid bulking agent for $235M
  • NuVasive reports mixed Q4 results
  • Is J&J’s COVID-19 vaccine linked to tinnitus?
  • UK passes post-Brexit medical device regulation
  • Stereotaxis up on Street-beating Q4 results
  • Nevro posts Street-beating Q4 results
  • Kala Pharmaceuticals slides on missed Q4 projections
  • FDA approves EndoClot hemostat for GI bleeding
  • Elekta names permanent CFO
  • NuVasive acquires Simplify Medical in $150M deal
  • Staar Surgical slides despite Street-beating Q4 results
  • Merit Medical ticks up on Street-beating Q4 results
  • Teleflex beats The Street with Q4 results

RSS From Medical Design & Outsourcing

  • Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
    The FDA announced today that it is allowing undiluted, frozen vials of the Pfizer-BioNTech COVID-19 vaccine to be transported and stored for up to two weeks at conventional temperatures commonly found in pharmaceutical freezers. The decision should allow for wider distribution of the vaccine to sites that do not have ultra-low temperature freezers. Pfizer asked… […]
  • 8 drug delivery innovations you need to know
    The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the… […]
  • Hoffer Plastics gains MedAccred certification again
    Injection molding company Hoffer Plastics (South Elgin, Ill.) announced that it has received the MedAccred re-certification from not-for-profit medtech audit provider MedAccred. MedAccred is a supply-chain oversight program of the Performance Review Institute. It conducts critical-process audits for its member OEMs to ensure their suppliers adhere to global regulations and requirements, and helps reduce the number… […]
  • UK passes post-Brexit medical device regulation
    The U.K. has enacted a new law governing medical devices and drugs, with a focus on patient safety. The Medicines and Medical Devices Act, introduced in July 2020, establishes the position of commissioner for patient safety to respond to public and patient complaints and concerns about drugs and medical devices. The law was necessitated by… […]
  • Integrated Polymer Solutions acquires IRP Group
    Integrated Polymer Solutions (“IPS”), a portfolio company of Arcline Investment Management, announced this week that it has acquired IRP Group. IRP designs and manufacturers elastomeric sealing components from its facilities in Southern California. Founded in 1999, the company is focused on the Class I and II medical device market as well as the aerospace &… […]
  • Interpower debuts plugs in new colors
    Interpower announced that its NEMA 5-20 hospital-grade plugs for use in North America now come in molded colors of clear, black or gray on 10-foot lengths of flexible cord. These molded plugs complement the company’s NEMA 5-20 hand-wired hospital-grade plugs. The North American 18A hospital-grade power cord on 14 AWG SJT cable and North American… […]
  • Portescap motors gain certification
    Portescap announced that its slotless brushless DC motors for respirators have received ISO 13485:2016 certification. Expanding on ISO 9001, this standard contains specific requirements for parts traceability and risk management activities throughout the design and development stages. It also requires process and software validations at defined intervals. Independent risk management and quality compliance firm DNV… […]
  • Instron launches update to product testing system
    Materials testing equipment and software developer Instron announced the launch of the Torsion Add-On 3.0 for universal testing systems. Recently redesigned to take advantage of the latest functionality offered by the new Instron 6800 series, this system offers a simpler, safer, and more intuitive user experience, according to Norwood, Mass.-based Instron. Instron introduced the Torsion… […]
  • Abiomed CEO Michael Minogue appointed as AdvaMed chairperson
    Medtech trade group AdvaMed today said it has appointed Abiomed (NSDQ:ABMD) president and CEO Michael Minogue as chairperson of the AdvaMed board of directors, effective immediately. Minogue will serve as chairperson of the trade association’s board of directors for two years. He has been a member of the board since 2007 and a member of the board… […]
  • Credit card-sized pump could enable ‘power clothing’ to help patients with mobility
    Robotic clothing that is entirely soft and could help people to move more easily is a step closer to reality thanks to the development of a new flexible and lightweight power system for soft robotics. The discovery by a team at the University of Bristol (UK) could pave the way for wearable assist devices for… […]
  • ACSYS Lasertechnik debuts quick-change laser system
    ACSYS Lasertechnik (Lenexa, Kan.) recently announced the development of its patent-pending, ultra-short pulse,  quick-change laser system for marking, engraving and cutting for medical device applications. The system uses a galvanometer scanner equipped with either f-theta marking optics or a laser cutting head to provide interchangeable flexibility and precision. When in marking mode, the system can… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS